These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 32658854)
1. [About population tests to detect anti-SARS-CoV-2 antibodies]. Kantor IN; Ritacco V Medicina (B Aires); 2020; 80 Suppl 3():87-88. PubMed ID: 32658854 [No Abstract] [Full Text] [Related]
2. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041 [No Abstract] [Full Text] [Related]
3. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG. Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140 [No Abstract] [Full Text] [Related]
8. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19. Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S mBio; 2020 Mar; 11(2):. PubMed ID: 32217609 [No Abstract] [Full Text] [Related]
9. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies. Goetz L; Yang J; Greene W; Zhu Y J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181 [No Abstract] [Full Text] [Related]
10. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19. Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2. Tollånes MC; Bakken Kran AM; Abildsnes E; Jenum PA; Breivik AC; Sandberg S Clin Chem Lab Med; 2020 Aug; 58(9):1595-1600. PubMed ID: 32598303 [TBL] [Abstract][Full Text] [Related]
12. The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population. Wang D; Jia X; Huang T; Wang H; Li S; Ren T; Nie H; Chen Z; Song C; Zhou Y; Ma W; Shen H Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658430 [No Abstract] [Full Text] [Related]
13. The Promise and Peril of Antibody Testing for COVID-19. Abbasi J JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958 [No Abstract] [Full Text] [Related]
15. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay. Tang MS; Hock KG; Logsdon NM; Hayes JE; Gronowski AM; Anderson NW; Farnsworth CW Clin Chem; 2020 Aug; 66(8):1107-1109. PubMed ID: 32484860 [No Abstract] [Full Text] [Related]
16. Covid-19 antibody tests: a briefing. Baraniuk C BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937 [No Abstract] [Full Text] [Related]
17. Serological characteristics of COVID-19 patients. Zhou M; Zhong J; Bi L; Shang P; Xing Y; Wang B; He J; Xu Y; Luo T; Ma M; Li Q Infect Dis (Lond); 2020 Oct; 52(10):749-750. PubMed ID: 32603629 [No Abstract] [Full Text] [Related]
18. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)]. Herrmann BL MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376 [TBL] [Abstract][Full Text] [Related]
19. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019 [No Abstract] [Full Text] [Related]
20. SARS-CoV-2 Serology: Much Hype, Little Data. Farnsworth CW; Anderson NW Clin Chem; 2020 Jul; 66(7):875-877. PubMed ID: 32343775 [No Abstract] [Full Text] [Related] [Next] [New Search]